MAXY - Maxygen, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MAXY - Maxygen, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (100)	12/13/2001 12:26:08 PM
From: Icebrg	Read Replies (1) of 262

Robertson Stephens wrote the following today. Maxygen, Inc.ab [NASDAQ: MAXY $19.45] 12-Month Price Target: $30.00 F2001E EPS: $(0.79) F2002E EPS: $(0.99) Buy Michael King, Biopharmaceuticals Investment Conclusion: Maxygen is emerging as an early drug discovery company having leveraged its core competency in molecular evolution to develop several human therapeutic and industrial products. While we are closing in on year-end, we remain confident that the company will meet its 2001 milestones this month or early next year including an addition human therapeutic deal, another industrial deal or two, a deal in a new product area and potentially even a joint venture. It looks like Maxygen will have a quite busy end of the year. Ice

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next